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Abstract — Khat leaves are widely used as a stimulant in East Africa and the Arabian Peninsula
and the effect of the material was formerly believed to be due to its content of norpseudoephed-
rine. Recently, however, a new alkaloid, cathinone, has been discovered in khat, and this
substance was found to be a potent compound with a pharmacological profile closely resembling
that of amphetamine. It was also found that cathinone has the same mechanism of action as
amphetamine, i.e. that it causes release at physiological catecholamine storage sites. The present
report summarizes the pharmacology of cathinone and shows that this alkaloid must be
considered to be the main active constituent of khat.
INTRODUCTION
The chewing of leaves of the khat bush (Catha
edulis, Celastraceae) has a stimulating effect
and causes a certain degree of euphoria. For
this reason, khat is widely consumed in the
areas where the plant grows, i.e. in certain
regions of East Africa and of the Arabian
Peninsula. Since only fresh leaves have the
desired effect, the khat habit has remained
endemic to these areas. However, mainly
because of the possibilities of modern trans-
portation, khat is now available to much larger
sections of the population, and it is estimated
that, at present, each day between five and ten
million people chew khat. Many of them tend
to compulsive khat consumption and develop
psychic dependence on the drug. Furthermore,
with the development of international air
travel, khat use tends to spread to countries far
away from the areas of cultivation, in
particular through the movement of emigrants.
Thus, cases of khat-induced psychosis have
recently been encountered in the United States
(Giannini and Castellani, 1982) and in Great
Britain (Gough and Cookson, 1984). The
medical problems that arise from khat
consumption are partly due to its effect on
mental health, and partly to the sympatho-
mimetic effects of the drug. Indeed, khat has
been recognized to have amphetamine-like
effects. Because of this, and because of the
serious socio-economic consequences of khat
use, the countries affected by the habit have
expressed their concern (Recommendations,
First International Conference on Khat, 1983)
and are now beginning to take steps for
reducing the availability of the drug (Proceed-
ings, WHO Intercountry Meeting on Khat,
1983).
The effects of khat have been described
centuries ago in the Arabic medical literature,
and knowledge of the khat habit came to
Europe mainly through the travel accounts of
Carsten Niebuhr at the end of the eighteenth
century (see Krikorian, 1983). The first
attempts to isolate the active principle of khat
were made about 100 years ago (Fluckiger and
Gerock, 1887), but it was Wolfes (1930) who
identified norpseudoephedrine in the leaves.
Up to about 1960 this substance was generally
believed to be the active principle of khat
(Winterfeld and Bernsmann, 1960; Alles etal.,
1961), although it had already been stated in
1941 by Briicke that the amount of nor-
pseudoephedrine present in khat was insuffi-
cient to account for the symptoms produced. In
view of this objection, and because of the
international problems associated with khat,
the Narcotics Laboratory of the United
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Nations reinvestigated the constituents of the
plant (Braenden, 1979; Szendrei, 1980). These
studies culminated in the isolation, in 1975, of
the ceto analogue of norpseudoephedrine (Fig.
1) from khat leaves, and the name
Since the effects of khat had been described
earlier as being reminiscent of those of amphe-
tamine (Eddy et al., 1965), (-)cathinone was
examined for amphetamine-like effects, with



















Fig. 1. The effect of (-)cathinone and (H-)norpseudoephedrine on the efflux of radioactivity from rat
nucleus accumbens tissue prelabelled with 3H-dopamine. Two preparations were perfused in parallel
and stimulated twice with either 3 u.M (—)cathinone followed by 24 nM (+)norpseudoephedrine (A),
or 9 u,M (-)cathinone followed by 72 (xM (+)norpseudoephedrine (A). Each fraction corresponds to 3
min of efflux. From Kalix (1983a).
(—)cathinone was suggested for this new alka-
loid (UN Document, 1975). Chemically,
(—)cathinone bears a close resemblance to
amphetamine, the only difference being that
the two hydrogens on the first carbon of the
amphetamine side chain are substituted by an
oxygen. Through further studies (Schorno et
al., 1982), it became evident that (-)cathinone
is a labile compound that is mainly present in
young leaves, and is biodegraded when the
leaves start to dry.
advisory group of the World Health Organiza-
tion (1980). When the somatic effects of the
new alkaloid were tested, it was found that
(—)cathinone, when administered to anaesthe-
tized cats or rats, caused a substantial increase
in blood pressure, and that it had a positive
inotropic and chronotropic effect in isolated
guinea pig heart. Furthermore, constrictions of
isolated rabbit ear artery were potentiated by
(-)cathinone, whose potency in this respect
was similar to that of (+)amphetamine. Taken
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together, these observations suggest that
(-)cathinone is responsible for the sympatho-
mimetic syndrome observed after khat con-
sumption.
The behavioural effects observed within the
framework of this study are of particular
interest, because the effect desired by khat
chewers involves CNS stimulation. It has been
found that (—)cathinone modifies the locomo-
tor activity of mice in a way analogous to that
of (+)amphetamine, and that, in this respect,
its potency is similar to that of
(+)amphetamine. Furthermore, it was found
that, like (+)amphetamine, (—)cathinone was
a potent anorectic, that tolerance developed to
this effect, and that there was cross-tolerance
between the effects of (—)cathinone and
(+)amphetamine (Foltin and Schuster, 1982).
It was also observed that (-)cathinone main-
tained the drug-seeking behaviour of rats that
had been habituated to (+)amphetamine.
Finally, it was shown that in monkeys trained
to press a lever for cocaine injections,
(-)cathinone elicited rates of responding that
were even higher than those obtained with
(-l-)amphetamine. Taken together, these ex-
periments demonstrate that (—)cathinone is a
potent amphetamine-like compound and is the
constituent of khat that is mainly responsible
for the CNS effects. Since (-)cathinone rein-
forces behaviour of test animals that gives
them access to this substance, it can be
assumed to be a dependence-producing consti-
tuent of khat.
Once the new alkaloid was made available to
pharmacologists, the initial studies of the
WHO Advisory Group were extended in
several directions. For example, the effects of
(-)cathinone on some metabolic (Nencini,
1980) and endocrine (Nencini et al, 1983a)
parameters, as well as the analgesic properties
of the new compound (Nencini and Ahmed,
1982; Nencini et al., 1984) were examined. The
cardiovascular effects of (—)cathinone were
investigated in anaesthetized dogs and
confirmed to be analogous to those of
(-l-)amphetamine (Kohli and Goldberg, 1982).
Another group made additional studies on the
behavioural effects of (—)cathinone (Foltin
and Schuster, 1981, 1982; Johanson and
Schuster, 1981) and also studied some neuro-
chemical effects. (Wagner et al., 1982). Zelger
et al. (1980) showed that rats injected with
(-)cathinone displayed the same stereotypical
behaviour as that observed after (-^ampheta-
mine administration.
These studies raised the question as to
whether (—)cathinone acts by the same
mechanism as (+)amphetamine, i.e. through
release of neurotransmitter at catechola-
minergic synapses. In order to investigate this,
experiments were performed in which the
effect of the alkaloid on isolated brain tissue
pre-incubated with 3H-dopamine was ex-
amined. When prelabelled slices of rabbit
striatum were superfused with solutions of
(-)cathinone, a rapid increase of the efflux of
radioactivity was observed (Kalix, 1980). Con-
centrations in the u.M range produced this
effect, which was found to be dose-dependent
and reversible (Kalix, 1981). (+)Norpseudo-
ephedrine had the same effect, but was approx-
imately eight times less potent (Fig. 1). The
amphetamine-like releasing effect of
(-)cathinone was also demonstrated on tissue
from the nucleus accumbens (Kalix, 1982), a
brain region thought to be involved in the
expression of amphetamine hypermotility
(Pijnenburg et al., 1975). It was also shown
that substances known to block the releasing
effect of (+)amphetamine prevented the
induction of release by (-)cathinone (Kalix,
1981, 1982). Thus, it was concluded that
(-)cathinone acts at dopaminergic synapses of
the CNS like (+)amphetamine, a view that is
now supported by neurochemical (Wagner et
al., 1982) and electrophysiological (Mereu et
al, 1983) data.
Amphetamine is also known to affect seroto-
ninergic pathways in the CNS (Sloviter et al,
1978) and has been shown to release serotonin
from rat corpus striatum in a dose-dependent
manner (Azzaro and Rutledge, 1973). In order
to determine whether (—)cathinone also
mimicks this aspect of amphetamine action,
the effect of (-)cathinone on the release of
radioactivity from rat striatal tissue prelabelled
with 3H-serotonin was studied. It was found
that a concentration three times higher was
needed to produce an effect of an amplitude
similar to that produced by a given concentra-
tion of (+)amphetamine (P. Kalix, manuscript
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in press). This means that, with regard to
release from CNS serotonin storage sites,
(—)cathinone appears to have no greater speci-
ficity than (+)amphetamine. There are,
however, indications in the literature that the
interaction with serotonin pathways might be
more important for the action of (-)cathinone
than for that of (+)amphetamine (Babayan et
al., 1983), possibly because the affinity of
(—)cathinone for serotonin receptors is about
four times greater than that of (+Am-
phetamine (Glennon and Liebowitz, 1982).
Since the consumption of khat causes a
number of symptoms of the sympathomimetic
type, especially at the cardiovascular level, an
investigation was made to determine whether
these were due to release of noradrenaline
from sympathetic nerve endings. Experiments
analogous to those on CNS tissue described
above were carried out with slices of rabbit
heart that had been prelabelled with 3H-
noradrenaline. It was found that in this tissue
superfusion with (—)cathinone caused a sub-
stantial increase in the release of radioactivity,
and the potency of (—)cathinone was greater
than in CNS material (Kalix, 1983a). In heart
tissue, as in the CNS, the effect of
(—)cathinone was of the same order of magni-
tude as that of (-t-)amphetamine, and it could
be modified by the same pharmacological
manipulations as those of (+)amphetamine
(Kalix, 19836). Surprisingly, (+)norpseu-
doephedrine was found to be equipotent to
(—)cathinone as regards the release from
peripheral noradrenaline sites (Kalix, 1983a).
Thus, at the cellular level both alkaloids
appear to contribute equally to the peripheral
effects of khat chewing. In vivo, however, the
factor of distribution probably plays an impor-
tant role, since the greater lipophilicity of
(—)cathinone favours its penetration into the
CNS. Therefore, it can be assumed that the
CNS stimulation resulting from khat chewing is
largely due to the (-)cathinone content of the
leaves, whereas for the peripheral effects
(+)norpseudoephedrine is of an importance at
least equal to that of (—)cathinone.
In summary, it can be said that khat is an
amphetamine-like plant material, the effects of
which can be accounted for by those of the
phenethylamines (—)cathinone and, to a lesser
extent, (+)norpseudoephedrine. In addition to
these two 'khatamines' the leaves also contain
the cathedulins (Baxter et al., 1976), an in-
teresting group of substances awaiting pharma-
cological investigation. The symptoms charac-
terizing drug dependence of the amphetamine
type and khat dependence are qualitatively
similar. However, long-term use of ampheta-
mine leads to the development of tolerance,
which is not apparent for khat (Eddy et al.,
1965). This difference may be due to the
impossibility of increasing the khat dose
beyond a certain limit (Lemordant, 1966). A
recent study seems to indicate however, that
habitual khat chewers develop a certain degree
of tolerance to the sympathomimetic effects of
the drug (Nencini etal., 19836), which suggests
that khat resembles amphetamine in this re-
spect too.
Among the recent publications on khat there
are also epidemiological studies (Baasher and
Sadoun, 1983; Elmi, 1983), one of which
analyses the prevalence of khat use in Somalia.
Since its appearance, however, the situation in
this country has changed profoundly, because
the importation and use of khat leaves have
been prohibited by government decree. It will
be interesting to see the long-term effect of
these restrictive measures — an effective ban
on khat could have a beneficial effect on public
health and alleviate the social problems associ-
ated with its use.
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